Tags |
|
|
Links |
|
|
Suggest - The IRS Says You Owe Money, But You Disagree
Hard as it is to believe, employees at the IRS are humans just like you and me. This means they make mistakes a
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
nd you need to let them know when this occurs.
The IRS has a computer system that is legendary. The legend is
The IRS has a computer system that is legendary. The legend is
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
ll about what a nightmare it is. Bill Gates gets headaches just thinking about it. Throw in the human element o
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
people using it and mistakes happen all the time. One area where this happens is the issuance of balance due n
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
tices to taxpayers.
Assume you prepare your taxes for 2006. You bite the bullet, write a check for the amount
Assume you prepare your taxes for 2006. You bite the bullet, write a check for the amount
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
ue and send it in on time. Heck, you even send it in early. Ah, you don’t have to deal with that mess again unt
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
il next year or so you think.
A couple months later, you receive a letter from the IRS. The letter is a form C
A couple months later, you receive a letter from the IRS. The letter is a form C
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
-14 filing giving you notice that the IRS thinks you failed to send in everything you owed for 2006. How could
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
his be?
The first thing to do is take a breath. If it is a CP-14 notice, you are not in trouble. A CP-14 notic
The first thing to do is take a breath. If it is a CP-14 notice, you are not in trouble. A CP-14 notic
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
is not used to give you notice that you didn’t report the correct tax amount due. It is simply used to tell yo
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
that the full amount you reported on your return was not received.
At this point, there are typically two thi
At this point, there are typically two thi
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
ngs that have happened. First, you forgot to send in the total amount due. This can often happen if you make qu
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
rterly payments and simply forgot to send off a check. Go through your records and determine if you actually se
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
t payment off and if the payment was cleared by your bank. If you find a problem, just send in the amount due.
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
On the other hand, the IRS may have made the error. For whatever reason, the IRS has a bad habit of applying pa
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
ments to the wrong taxpayer accounts. If you are sure all payments were made, it is time to take action. Get co
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
pies of the checks for all your payments. Next, call the telephone number on the CP-14 notice [it varies by you
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
location]. The person you speak with will hunt through the system to try to find the problem. If he or she can
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
t, you will be asked to send in copies of your checks and the IRS will then resolve the matter.
At the end of
At the end of
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
he day, the CP-14 notice is nothing to panic about. Figure out if you paid and then take the appropriate action
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.suggest.org.ua/article/118785/suggest-The-IRS-Says-You-Owe-Money-But-You-Disagree.html">The IRS Says You Owe Money, But You Disagree</a>
BB link (for phorums):
[url=http://www.suggest.org.ua/article/118785/suggest-The-IRS-Says-You-Owe-Money-But-You-Disagree.html]The IRS Says You Owe Money, But You Disagree[/url]
Related Articles:
Networking in the Nude (And Other Nontraditional Ways to Build Mutually Beneficial Relationships)
Cold Calling Considerations and the Warm Up!
A Couple Of Basic Killer Internet Marketing Techniques
Bookmark it:
|